Skip to content
Recovery & autonomic healthEvidence review3 min read

People with metabolic syndrome have lower short-term heart rate variability than healthy controls

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Short-Term Heart Rate Variability in Metabolic Syndrome: A Systematic Review and Meta-Analysis. · Journal of clinical medicine · 2023 · Original paper ↗

Key takeaway

In a meta-analysis of 19 studies, people with metabolic syndrome had lower SDNN (-0.36; CI -0.44 to -0.28), rMSSD (-7.59), HF and LF than healthy controls. Studies were short recordings of 30 minutes or less, and sex-specific results differed, so effects in each sex remain unclear.

Study design

Evidence review

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Heart rate variability (HRV) reflects how the autonomic nervous system adjusts heart rhythm, and it may be affected by metabolic syndrome, a cluster of risk factors for heart disease and diabetes. The authors compared short-term HRV in people with metabolic syndrome and healthy controls.

Who and how

Systematic review and meta-analysis following PRISMA guidelines and registered in PROSPERO (CRD42022358975). The authors searched electronic databases for studies with short-term HRV recordings (30 minutes or less) comparing people with metabolic syndrome (MS) to healthy controls. Twenty-eight articles were included in the qualitative synthesis and 19 in the meta-analysis. Sub-analyses were done by sex. The abstract does not report the total number of participants.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    People with MS had lower SDNN (-0.36 [-0.44, -0.28], p < 0.001) and rMSSD (-7.59 [-9.98, -5.19], p < 0.001), both time-domain measures of overall and beat-to-beat variability.
  2. 2
    Frequency-domain measures were also lower: HF (-0.36 [-0.51, -0.20], p < 0.00001) and LF (-0.24 [-0.38, -0.1], p = 0.001).
  3. 3
    In women, SDNN (-0.99 [-1.45, -0.52], p < 0.001), rMSSD (-10.18 [-16.85, -3.52], p < 0.01) and HF (-1.04 [-1.97, -0.1], p < 0.05) were lower. In men, only LF was significantly lower (-0.26 [-0.5, -0.02], p < 0.05).
  4. 4
    Non-linear HRV measures could not be meta-analysed, and for rMSSD and LF/HF the sex-specific analysis was possible in only one sex.

Limits & uncertainty

  1. 1
    The studies compared groups at one point in time, so the review cannot tell whether low HRV precedes metabolic syndrome or follows from it.
  2. 2
    SDNN and rMSSD were pooled on different scales (small values for SDNN and larger ones for rMSSD), and the abstract does not explain the units or heterogeneity.
  3. 3
    The sex-specific analysis had gaps: for some measures data existed for only men or only women, and mixed and sex-split results differed, so conclusions on sex differences are tentative.
  4. 4
    This reading is based on the abstract only.

What to take from it

Lower HRV is associated with metabolic syndrome in group averages, and the pattern may differ between women and men. It does not make HRV a test for metabolic syndrome in any one person. A diagnosis rests on blood pressure, waist size, blood sugar and lipids, and your clinician should make it.

Reading your own data

Wearable HRV (often rMSSD or an SDNN-like value) is usually measured overnight or in short morning readings. Compare only against your own baseline on the same device and conditions, because absolute values differ between brands and a single low night says little.

How to read this evidence

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Our aim was to determine the differences in short-term heart rate variability (HRV) between patients with metabolic syndrome (MS) and healthy controls.

Methods

We searched electronic databases for primary works with short-term HRV recordings (≤30 min) that made comparisons between individuals with MS versus healthy controls. This systematic review and meta-analysis (MA) was performed according to PRISMA guidelines and registered at PROSPERO (CRD42022358975).

Results

Twenty-eight articles were included in the qualitative synthesis and nineteen met the criteria for the MA. Patients with MS showed decreased SDNN (-0.36 [-0.44, -0.28], p < 0.001), rMSSD (-7.59 [-9.98, -5.19], p < 0.001), HF (-0.36 [-0.51, -0.20], p < 0.00001) and LF (-0.24 [-0.38, -0.1], p = 0.001). In subsequent subanalyses, we found a decrease in SDNN (-0.99 (-1.45, -0.52], p < 0.001), rMSSD (-10.18 [-16.85, -3.52], p < 0.01) and HF (-1.04 [-1.97, -0.1] p < 0.05) in women. In men, only LF showed a significant lower value (-0.26 [-0.5, -0.02], p < 0.05). We could not perform MA for non-linear variables.

Conclusions

Patients with MS showed changes in time-domain analyses, with lower values in SDNN and rMSSD. Regarding frequency-domain analyses, MS patients showed a decrease in HF and LF When sex was used as a grouping variable, the MA was only possible in one of both sexes (men or women) in rMSSD and LF/HF. Lastly, when data for both men and women were available, subanalyses showed a different behavior compared to mixed analyses for SDNN, HF and LF, which might point towards a different impact of MS in men and women.

Sources & attribution

Short-Term Heart Rate Variability in Metabolic Syndrome: A Systematic Review and Meta-Analysis.

Ortiz-Guzmán JE, Mollà-Casanova S, Serra-Añó P, Arias-Mutis ÓJ, Calvo C, Bizy A, Alberola A, Chorro FJ, Zarzoso M.

Journal of clinical medicine · 2023-09-19

DOI: 10.3390/jcm12186051 ↗PubMed · 37762990 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Research article

Short-term HRV was higher during slow breathing in 962 military men, injured or not

In 962 military men (median age 37.6 years), every short-term heart rate variability (HRV) measure was higher during slow breathing at six breaths a minute than during spontaneous breathing, injured or not; in fast resting breathers RMSSD rose from 15.57 to 21.89 ms. It was one session in a fixed order, so it shows an immediate effect, not lasting benefit.

European Journal of Applied Physiology

In-depth explainersRead study →
·Trial meta-analysis

Cold-water immersion: no strength gain, briefly weaker jumps, soreness relief uncertain

Across 22 randomised trials (375 participants, mostly men), one cold-water immersion after exercise did not change maximal isometric strength (g 0.08, 95% CI −0.11 to 0.26) and was followed by weaker jumping straight afterwards (g −0.68), gone by 24–48 hours. Lower soreness and creatine kinase looked favourable but weakened in sensitivity checks, and certainty was low to very low.

PeerJ

In-depth explainersRead study →
·Evidence review

Cold-water immersion after hard exercise: less soreness, better power, no strength gain

In a meta-analysis of 52 randomised trials, cold-water immersion after high-intensity exercise was followed 24 hours later by lower soreness (SMD −0.89), higher perceived recovery (0.66) and better muscular power (0.22), with no effect on strength. Participants could not be blinded, most were men, and many pooled results rest on few studies with high heterogeneity.

Sports Medicine

In-depth explainersRead study →
·Methods & interpretation

Acute:chronic workload ratio: no evidence it can reduce injury risk, authors argue

The authors argue there is no evidence for using the acute:chronic workload ratio (ACWR) in training-load management or to reduce injury risk: no study has properly estimated a causal effect, and the ratio is statistically inaccurate and ambiguous. This is a methodological critique, not a new data analysis, so it does not show that training load is unrelated to injury.

International Journal of Sports Physiology and Performance

In-depth explainersRead study →
Recovery & autonomic health →